Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
US7241756B2 · kind B2 · utility
5Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2006 |
| Grant date | Jul 10, 2007 |
| Priority date | — |
| Expiry date | Jun 1, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the treatment of diabetes mellitus, especially Type 2 diabetes and conditions associated with diabetes mellitus in a mammal such as a human, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of a dipeptidyl peptidase IV inhibitor and another antidiabetic agent, to a mammal in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.